Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma
暂无分享,去创建一个
Y. Kajiyama | Tsuyoshi Saito | T. Yao | H. Orita | T. Fukunaga | Sho Tsuyama | S. Mine | Takuo Hayashi | M. Tsurumaru | T. Hashimoto | Y. Yanai | Motomi Nasu | T. Hayashi
[1] Yingying Xu,et al. Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus , 2021, International journal of general medicine.
[2] H. Miyata,et al. Comprehensive registry of esophageal cancer in Japan, 2013 , 2020, Esophagus.
[3] Tsuyoshi Saito,et al. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation. , 2019, Human pathology.
[4] Y. Tachimori,et al. Comprehensive registry of esophageal cancer in Japan, 2012 , 2019, Esophagus.
[5] N. Tunariu,et al. Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin‐based Chemotherapy in Colorectal Cancer , 2018, Clinical colorectal cancer.
[6] Tsuyoshi Saito,et al. Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma. , 2018, Human pathology.
[7] Gang Chen,et al. The genomic landscape of small cell carcinoma of the esophagus , 2018, Cell Research.
[8] S. Ozawa,et al. Clinicopahological features of superficial basaloid squamous cell carcinoma of the esophagus. , 2017, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[9] Y. Kajiyama,et al. PTCH1 mutation is a frequent event in oesophageal basaloid squamous cell carcinoma. , 2015, Mutagenesis.
[10] E. Oki,et al. Molecular Characteristics of Basaloid Squamous Cell Carcinoma of the Esophagus: Analysis of KRAS, BRAF, and PIK3CA Mutations and LINE-1 Methylation , 2015, Annals of Surgical Oncology.
[11] Y. Kajiyama,et al. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma , 2014, Virchows Archiv.
[12] A. Ahani,et al. Genotyping of Polymorphic Microsatellite Markers Linked to RB1 Locus in Iranian Population , 2012, Avicenna journal of medical biotechnology.
[13] B. Conn,et al. Assessment of TP53 Mutations in Benign and Malignant Salivary Gland Neoplasms , 2012, PloS one.
[14] Di-tian Liu,et al. Basaloid squamous cell carcinoma of the esophagus , 2012, Journal of Cancer Research and Clinical Oncology.
[15] E. Oki,et al. Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: Analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients , 2011, Journal of surgical oncology.
[16] K. Takubo,et al. Clinicopathologic characteristics of basaloid squamous carcinoma of the esophagus , 2011, Esophagus.
[17] M. Sarbia,et al. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus , 2007, British Journal of Cancer.
[18] J. Wong,et al. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator , 2001, The Journal of pathology.
[19] Jang,et al. Basaloid squamous carcinoma of the oesophagus: a distinct neoplasm with multipotential differentiation , 2000, Histopathology.
[20] M. Vuillaume,et al. High incidence of cancer in a family segregating a mutation of the ATM gene: Possible role of ATM heterozygosity in cancer , 1999, Human mutation.
[21] Patricia L. Blount,et al. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.
[22] Bai-hua Zhang,et al. Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a retrospective analysis of 142 cases. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[23] Tomotaka Sobue,et al. Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. , 2011, Japanese journal of clinical oncology.
[24] F. Bosman,et al. WHO Classification of Tumours of the Digestive System , 2010 .
[25] K. Brown,et al. Short Communication Ataxia-Telangiectasia-Mutated (ATM) Gene in Head and Neck Squamous Cell Carcinoma: Promoter Hypermethylation with Clinical Correlation in 100 Cases , 2004 .